{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T22:33:49Z","timestamp":1780353229296,"version":"3.54.1"},"reference-count":97,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic and Interventional Imaging"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.diii.2021.01.007","type":"journal-article","created":{"date-parts":[[2021,1,30]],"date-time":"2021-01-30T08:50:07Z","timestamp":1611996607000},"page":"131-139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Kidney and contrast media: Common viewpoint of the French Nephrology societies (SFNDT, FIRN, CJN) and the French Radiological Society (SFR) following ESUR guidelines"],"prefix":"10.1016","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5958-8924","authenticated-orcid":false,"given":"Louis","family":"de Laforcade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9451-0372","authenticated-orcid":false,"given":"Micka\u00ebl","family":"Bobot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-France","family":"Bellin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Cl\u00e9ment","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Grang\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Grenier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Wynckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5953-5785","authenticated-orcid":false,"given":"Dominique","family":"Guerrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diii.2021.01.007_bib0490","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1007\/s00330-017-5246-5","article-title":"Post-contrast acute kidney injury - Part 1: definition, clinical features, incidence, role of contrast medium and risk factors: recommendations for updated ESUR Contrast Medium Safety Committee guidelines","volume":"28","author":"van der Molen","year":"2018","journal-title":"Eur Radiol"},{"key":"10.1016\/j.diii.2021.01.007_bib0495","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1007\/s00330-017-5247-4","article-title":"Post-contrast acute kidney injury. Part 2: risk stratification, role of hydration and other prophylactic measures, patients taking metformin and chronic dialysis patients: Recommendations for updated ESUR Contrast Medium Safety Committee guidelines","volume":"28","author":"van der Molen","year":"2018","journal-title":"Eur Radiol"},{"key":"10.1016\/j.diii.2021.01.007_bib0500","doi-asserted-by":"crossref","DOI":"10.1159\/000339789","article-title":"KDIGO clinical practice guidelines for acute kidney injury","volume":"120","author":"Khwaja","year":"2012","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.diii.2021.01.007_bib0505","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJM199403313301301","article-title":"The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group","volume":"330","author":"Klahr","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diii.2021.01.007_bib0510","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diii.2021.01.007_bib0515","unstructured":"Haute Autorit\u00e9 de Sant\u00e9. \u00c9valuation du d\u00e9bit de filtration glom\u00e9rulaire, et du dosage de la cr\u00e9atinin\u00e9mie dans le diagnostic de la maladie r\u00e9nale chronique chez l\u2019adulte - Rapport d\u2019\u00e9valuation. (https:\/\/www.has-sante.fr\/jcms\/c_1064297\/fr\/evaluation-du-debit-de-filtration-glomerulaire-et-du-dosage-de-la-creatininemie-dans-le-diagnostic-de-la-maladie-renale-chronique-chez-l-adulte-rapport-d-evaluation). (accessed April 27, 2020)."},{"key":"10.1016\/j.diii.2021.01.007_bib0520","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1056\/NEJMra1805256","article-title":"Contrast-associated acute kidney injury","volume":"380","author":"Mehran","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diii.2021.01.007_bib0525","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1148\/radiol.12121823","article-title":"Intravenous contrast material-induced nephropathy: causal or coincident phenomenon?","volume":"267","author":"McDonald","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.diii.2021.01.007_bib0530","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.ejrad.2014.02.014","article-title":"Fluctuations in eGFR in relation to unenhanced and enhanced MRI and CT outpatients","volume":"83","author":"Azzouz","year":"2014","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.diii.2021.01.007_bib0535","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2215\/CJN.02580607","article-title":"Prevention of contrast-induced nephropathy with volume expansion","volume":"3","author":"Weisbord","year":"2008","journal-title":"CJASN"},{"key":"10.1016\/j.diii.2021.01.007_bib0540","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/S0140-6736(17)30057-0","article-title":"Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial","volume":"389","author":"Nijssen","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.diii.2021.01.007_bib0545","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00261-015-0611-9","article-title":"Risk of contrast-induced nephropathy for patients receiving intravenous vs. intra-arterial iodixanol administration","volume":"41","author":"Tong","year":"2016","journal-title":"Abdom Radiol"},{"key":"10.1016\/j.diii.2021.01.007_bib0550","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.114.002212","article-title":"Association between acute kidney injury and in-hospital mortality in patients undergoing percutaneous coronary interventions","volume":"8","author":"Kooiman","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.diii.2021.01.007_bib0555","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1148\/radiol.12121394","article-title":"Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material","volume":"267","author":"Davenport","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.diii.2021.01.007_bib0560","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1148\/radiol.14132418","article-title":"Intravenous contrast material exposure is not an independent risk factor for dialysis or mortality","volume":"273","author":"McDonald","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.diii.2021.01.007_bib0565","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1007\/s00134-017-4699-y","article-title":"Post-contrast acute kidney injury in intensive care unit patients: a propensity score-adjusted study","volume":"43","author":"McDonald","year":"2017","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.diii.2021.01.007_bib0570","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00134-017-4700-9","article-title":"Contrast-associated acute kidney injury in the critically ill: systematic review and Bayesian meta-analysis","volume":"43","author":"Ehrmann","year":"2017","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.diii.2021.01.007_bib0575","article-title":"Epidemiology and prognostic implications of contrast-induced nephropathy","volume":"98","author":"McCullough","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.diii.2021.01.007_bib0580","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcin.2013.06.016","article-title":"Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry","volume":"7","author":"Tsai","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.diii.2021.01.007_bib0585","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3109\/0886022X.2015.1044399","article-title":"Avoidance of polypharmacy and excessive blood pressure control is associated with improved renal function in older patients","volume":"37","author":"Franco Palacios","year":"2015","journal-title":"Ren Fail"},{"key":"10.1016\/j.diii.2021.01.007_bib0590","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2214\/AJR.15.14329","article-title":"Nephrotoxic polypharmacy and risk of contrast medium-induced nephropathy in hospitalized patients undergoing contrast-enhanced CT","volume":"205","author":"Ho","year":"2015","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.diii.2021.01.007_bib0595","doi-asserted-by":"crossref","first-page":"e0129747","DOI":"10.1371\/journal.pone.0129747","article-title":"The effect of renin-angiotensin-aldosterone system blockade medications on contrast-induced nephropathy in patients undergoing coronary angiography: a meta-analysis","volume":"10","author":"Wu","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.diii.2021.01.007_bib0600","doi-asserted-by":"crossref","first-page":"e387","DOI":"10.1016\/j.ejrad.2013.04.029","article-title":"Contrast induced nephropathy in patients undergoing intravenous (IV) contrast enhanced computed tomography (CECT) and the relationship with risk factors: a meta-analysis","volume":"82","author":"Moos","year":"2013","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.diii.2021.01.007_bib0605","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s12882-017-0673-8","article-title":"Non-steroidal anti-inflammatory drug induced acute kidney injury in the community dwelling general population and people with chronic kidney disease: systematic review and meta-analysis","volume":"18","author":"Zhang","year":"2017","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.diii.2021.01.007_bib0610","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/fampra\/cms086","article-title":"Non-steroidal anti-inflammatory drugs and chronic kidney disease progression: a systematic review","volume":"30","author":"Nderitu","year":"2013","journal-title":"Fam Pract"},{"key":"10.1016\/j.diii.2021.01.007_bib0615","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1111\/dom.12974","article-title":"Metformin-associated lactic acidosis (MALA): moving towards a new paradigm","volume":"19","author":"Lalau","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diii.2021.01.007_bib0620","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1111\/dom.12978","article-title":"Acute kidney injury, plasma lactate concentrations and lactic acidosis in metformin users: a GoDarts study","volume":"19","author":"Connelly","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diii.2021.01.007_bib0625","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1111\/dom.12994","article-title":"Metformin-associated lactic acidosis: moving towards a new paradigm?","volume":"19","author":"Bicsak","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diii.2021.01.007_bib0630","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1710933","article-title":"Outcomes after angiography with sodium bicarbonate and acetylcysteine","volume":"378","author":"Weisbord","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diii.2021.01.007_bib0635","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/15563650.2019.1648816","article-title":"Metformin-related lactic acidosis with acute kidney injury: results of a French observational multicenter study","volume":"58","author":"Corchia","year":"2020","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.diii.2021.01.007_bib0640","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ijcard.2007.05.004","article-title":"Clinical outcomes of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: a prospective, multicenter, randomized study to analyze the effect of hydration and acetylcysteine","volume":"126","author":"Chen","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.diii.2021.01.007_bib0645","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.2169\/internalmedicine.53.1853","article-title":"Remedial hydration reduces the incidence of contrast-induced nephropathy and short-term adverse events in patients with ST-segment elevation myocardial infarction: a single-center, randomized trial","volume":"53","author":"Luo","year":"2014","journal-title":"Intern Med"},{"key":"10.1016\/j.diii.2021.01.007_bib0650","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.amjcard.2015.02.004","article-title":"Role of hydration in contrast-induced nephropathy in patients who underwent primary percutaneous coronary intervention","volume":"115","author":"Jurado-Rom\u00e1n","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.diii.2021.01.007_bib0655","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1111\/jth.12701","article-title":"Randomised trial of no hydration vs. sodium bicarbonate hydration in patients with chronic kidney disease undergoing acute computed tomography-pulmonary angiography","volume":"12","author":"Kooiman","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.diii.2021.01.007_bib0660","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1093\/ndt\/gfl133","article-title":"A randomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients","volume":"21","author":"Dussol","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.diii.2021.01.007_bib0665","doi-asserted-by":"crossref","first-page":"C29","DOI":"10.1159\/000066641","article-title":"A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity","volume":"93","author":"Trivedi","year":"2003","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.diii.2021.01.007_bib0670","doi-asserted-by":"crossref","first-page":"e000317","DOI":"10.1136\/openhrt-2015-000317","article-title":"Systematic oral hydration with water is similar to parenteral hydration for prevention of contrast-induced nephropathy: an updated meta-analysis of randomised clinical data","volume":"2","author":"Agarwal","year":"2015","journal-title":"Open Heart"},{"key":"10.1016\/j.diii.2021.01.007_bib0675","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1001\/jama.291.19.2328","article-title":"Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial","volume":"291","author":"Merten","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.diii.2021.01.007_bib0680","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1161\/CIRCULATIONAHA.106.687152","article-title":"Renal insufficiency following contrast media administration trial (REMEDIAL): a randomized comparison of 3 preventive strategies","volume":"115","author":"Briguori","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.diii.2021.01.007_bib0685","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1093\/eurheartj\/ehr501","article-title":"Sodium chloride vs. sodium bicarbonate for the prevention of contrast medium-induced nephropathy: a randomized controlled trial","volume":"33","author":"Klima","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.diii.2021.01.007_bib0690","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/MCA.0b013e3283021ac6","article-title":"Renal insufficiency following radiocontrast exposure trial (REINFORCE): a randomized comparison of sodium bicarbonate versus sodium chloride hydration for the prevention of contrast-induced nephropathy","volume":"19","author":"Adolph","year":"2008","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.diii.2021.01.007_bib0695","doi-asserted-by":"crossref","first-page":"631","DOI":"10.7326\/0003-4819-151-9-200911030-00008","article-title":"Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy","volume":"151","author":"Zoungas","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diii.2021.01.007_bib0700","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1001\/archinte.162.3.329","article-title":"Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty","volume":"162","author":"Mueller","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.diii.2021.01.007_bib0705","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1001\/jama.2012.13356","article-title":"Association between a chloride-liberal vs. chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults","volume":"308","author":"Yunos","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.diii.2021.01.007_bib0710","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1711584","article-title":"Balanced crystalloids versus saline in critically ill adults","volume":"378","author":"Semler","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diii.2021.01.007_bib0715","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1711586","article-title":"Balanced crystalloids versus saline in noncritically ill adults","volume":"378","author":"Self","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diii.2021.01.007_bib0720","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/S0140-6736(14)60689-9","article-title":"Haemodynamic-guided fluid administration for the prevention of contrast-induced acute kidney injury: the POSEIDON randomised controlled trial","volume":"383","author":"Brar","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.diii.2021.01.007_bib0725","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1536\/ihj.17-066","article-title":"Safe hydration to prevent contrast-induced acute kidney injury and worsening heart failure in patients with renal insufficiency and heart failure undergoing coronary angiography or percutaneous coronary intervention","volume":"60","author":"Bei","year":"2019","journal-title":"Int Heart J"},{"key":"10.1016\/j.diii.2021.01.007_bib0730","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/ndt\/gfu025","article-title":"A randomized comparison of 1-h sodium bicarbonate hydration versus standard peri-procedural saline hydration in patients with chronic kidney disease undergoing intravenous contrast-enhanced computerized tomography","volume":"29","author":"Kooiman","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.diii.2021.01.007_bib0735","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/MCA.0b013e328351aacc","article-title":"Intrarenal application of N-acetylcysteine for the prevention of contrast medium-induced nephropathy in primary angioplasty","volume":"23","author":"Aslanger","year":"2012","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.diii.2021.01.007_bib0740","doi-asserted-by":"crossref","first-page":"e107602","DOI":"10.1371\/journal.pone.0107602","article-title":"Do intravenous N-acetylcysteine and sodium bicarbonate prevent high osmolal contrast-induced acute kidney injury? A randomized controlled trial","volume":"9","author":"Inda-Filho","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.diii.2021.01.007_bib0745","first-page":"921","article-title":"A randomized trial of intravenous n-acetylcysteine to prevent contrast induced nephropathy in acute coronary syndromes","volume":"79","author":"Jaffery","year":"2012","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.diii.2021.01.007_bib0750","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1177\/0003319712467223","article-title":"The role of N--acetylcysteine in the prevention of contrast-induced nephropathy in patients undergoing peripheral angiography: a structured review and meta-analysis","volume":"64","author":"O'Sullivan","year":"2013","journal-title":"Angiology"},{"key":"10.1016\/j.diii.2021.01.007_bib0755","doi-asserted-by":"crossref","first-page":"406","DOI":"10.7326\/M15-1456","article-title":"Effectiveness of prevention strategies for contrast-induced nephropathy: a systematic review and meta-analysis","volume":"164","author":"Subramaniam","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diii.2021.01.007_bib0760","doi-asserted-by":"crossref","first-page":"e172","DOI":"10.1097\/MJT.0b013e31829dbc1c","article-title":"Role of N-acetylcysteine to prevent contrast-induced nephropathy: a meta-analysis","volume":"23","author":"Loomba","year":"2016","journal-title":"Am J Ther"},{"key":"10.1016\/j.diii.2021.01.007_bib0765","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1161\/CIRCINTERVENTIONS.112.000149","article-title":"Acetylcysteine for the prevention of renal outcomes in patients with diabetes mellitus undergoing coronary and peripheral vascular angiography: a substudy of the acetylcysteine for contrast-induced nephropathy trial","volume":"6","author":"Berwanger","year":"2013","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.diii.2021.01.007_bib0770","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1161\/CIRCULATIONAHA.111.038943","article-title":"Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT)","volume":"124","author":"ACT Investigators","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.diii.2021.01.007_bib0775","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/s12882-018-1113-0","article-title":"Effectiveness of contrast-associated acute kidney injury prevention methods; a systematic review and network meta-analysis","volume":"19","author":"Ahmed","year":"2018","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.diii.2021.01.007_bib0780","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ehj.2003.11.016","article-title":"Standard vs. double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity","volume":"25","author":"Briguori","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.diii.2021.01.007_bib0785","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1016\/S0735-1097(03)00487-X","article-title":"A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study","volume":"41","author":"Baker","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.diii.2021.01.007_bib0790","doi-asserted-by":"crossref","first-page":"e003968","DOI":"10.1161\/JAHA.116.003968","article-title":"Effectiveness of n-acetylcysteine for the prevention of contrast-induced nephropathy: a systematic review and meta-analysis of randomized controlled trials","volume":"5","author":"Xu","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.diii.2021.01.007_bib0795","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1177\/0003319716661445","article-title":"Strategies preventing contrast-induced nephropathy after coronary angiography: a comprehensive meta-analysis and systematic review of 125 randomized controlled trials","volume":"68","author":"Ali-Hasan-Al-Saegh","year":"2017","journal-title":"Angiology"},{"key":"10.1016\/j.diii.2021.01.007_bib0800","doi-asserted-by":"crossref","first-page":"e000864","DOI":"10.1136\/openhrt-2018-000864","article-title":"Pharmacological interventions for the prevention of contrast-induced acute kidney injury in high-risk adult patients undergoing coronary angiography: a systematic review and meta-analysis of randomised controlled trials","volume":"6","author":"Sharp","year":"2019","journal-title":"Open Heart"},{"key":"10.1016\/j.diii.2021.01.007_bib0805","doi-asserted-by":"crossref","first-page":"e19473","DOI":"10.1097\/MD.0000000000019473","article-title":"Beneficial effect of statin on preventing contrast-induced acute kidney injury in patients with renal insufficiency: a meta-analysis","volume":"99","author":"Cho","year":"2020","journal-title":"Medicine"},{"key":"10.1016\/j.diii.2021.01.007_bib0810","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1097\/MJT.0000000000000126","article-title":"3-Hydroxy-3-methylglutaryl-CoA reductase enzyme inhibitors for prevention of contrast-induced nephropathy: a meta-analysis of prospective randomized controlled studies","volume":"22","author":"Briasoulis","year":"2015","journal-title":"Am J Ther"},{"key":"10.1016\/j.diii.2021.01.007_bib0815","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/0003319718801246","article-title":"Comparative efficacy of statins for prevention of contrast-induced acute kidney injury in patients with chronic kidney disease: a network meta-analysis","volume":"70","author":"Zhou","year":"2019","journal-title":"Angiology"},{"key":"10.1016\/j.diii.2021.01.007_bib0820","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/MNH.0000000000000261","article-title":"Statins for the prevention of contrast-induced acute kidney injury","volume":"25","author":"Vanmassenhove","year":"2016","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.diii.2021.01.007_bib0825","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/j.jacc.2013.07.065","article-title":"Does ascorbic acid protect against contrast-induced acute kidney injury in patients undergoing coronary angiography: a systematic review with meta-analysis of randomized, controlled trials","volume":"62","author":"Sadat","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.diii.2021.01.007_bib0830","doi-asserted-by":"crossref","first-page":"24","DOI":"10.5414\/CN109815","article-title":"Effects of allopurinol pretreatment on the risk of contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials","volume":"93","author":"Xin","year":"2020","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.diii.2021.01.007_bib0835","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/FJC.0000000000000663","article-title":"Allopurinol administration for the prevention of contrast-induced nephropathy: a network meta-analysis with trial sequential analysis","volume":"73","author":"Bellos","year":"2019","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.diii.2021.01.007_bib0840","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jacc.2013.04.012","article-title":"Oxygen pre-conditioning prevents contrast-induced nephropathy (OPtion CIN Study)","volume":"62","author":"Sekiguchi","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.diii.2021.01.007_bib0845","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1053\/j.ajkd.2012.02.332","article-title":"Effect of theophylline on prevention of contrast-induced acute kidney injury: a meta-analysis of randomized controlled trials","volume":"60","author":"Dai","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.diii.2021.01.007_bib0850","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.clinimag.2015.02.003","article-title":"Fenoldopam for the prevention of contrast-induced nephropathy (CIN)-do we need more trials? A meta-analysis","volume":"39","author":"Naeem","year":"2015","journal-title":"Clin Imaging"},{"key":"10.1016\/j.diii.2021.01.007_bib0855","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1007\/s00330-002-1629-2","article-title":"Contrast Media Safety Committee of the European Society of Urogenital Radiology (ESUR). Dialysis and contrast media","volume":"12","author":"Morcos","year":"2002","journal-title":"Eur Radiol"},{"key":"10.1016\/j.diii.2021.01.007_bib0860","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000069153","article-title":"Does continuous venovenous hemodiafiltration concomitant with radiological procedures provide a significant and safe removal of the iodinated contrast ioversol?","volume":"21","author":"Gabutti","year":"2003","journal-title":"Blood Purif"},{"key":"10.1016\/j.diii.2021.01.007_bib0865","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1093\/ndt\/gfi327","article-title":"Effect of iodinated contrast agents on residual renal function in PD patients","volume":"21","author":"Moranne","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.diii.2021.01.007_bib0870","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1093\/ndt\/gfi023","article-title":"Effect of radio contrast media on residual renal function in peritoneal dialysis patient: a prospective study","volume":"21","author":"Dittrich","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.diii.2021.01.007_bib0875","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/clc.4960291105","article-title":"The effect of coronary angiography on residual renal function in patients on peritoneal dialysis","volume":"29","author":"Weisbord","year":"2006","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.diii.2021.01.007_bib0880","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00270-009-9715-3","article-title":"Effect of intravascular iodinated contrast media on natural course of end-stage renal disease progression in hemodialysis patients: a prospective study","volume":"33","author":"Janousek","year":"2010","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.diii.2021.01.007_bib0885","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1210\/jc.2014-3292","article-title":"A review: Radiographic iodinated contrast media-induced thyroid dysfunction","volume":"100","author":"Lee","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diii.2021.01.007_bib0890","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1210\/jc.2016-1330","article-title":"Thyroid dysfunction in children exposed to iodinated contrast media","volume":"101","author":"Barr","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diii.2021.01.007_bib0895","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3747\/pdi.2010.00202","article-title":"Prevalence of clinical and subclinical thyroid disease in a peritoneal dialysis population","volume":"32","author":"Ng","year":"2012","journal-title":"Perit Dial Int"},{"key":"10.1016\/j.diii.2021.01.007_bib0900","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/00004424-199907000-00001","article-title":"Safety and pharmacokinetic profile of gadobenate dimeglumine in subjects with renal impairment","volume":"34","author":"Swan","year":"1999","journal-title":"Invest Radiol"},{"key":"10.1016\/j.diii.2021.01.007_bib0905","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/(SICI)1522-2586(199902)9:2<317::AID-JMRI25>3.0.CO;2-B","article-title":"Pharmacokinetics, safety, and tolerability of gadoversetamide injection (OptiMARK) in subjects with central nervous system or liver pathology and varying degrees of renal function","volume":"9","author":"Swan","year":"1999","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.diii.2021.01.007_bib0910","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/ndt\/17.5.824","article-title":"Gadolinium as an alternative contrast agent for diagnostic and interventional angiographic procedures in patients with impaired renal function","volume":"17","author":"Rieger","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.diii.2021.01.007_bib0915","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2215\/CJN.06011108","article-title":"Current status of gadolinium toxicity in patients with kidney disease","volume":"4","author":"Perazella","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.diii.2021.01.007_bib0920","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1148\/radiol.2503080253","article-title":"Renal safety of gadolinium-based contrast media in patients with chronic renal insufficiency","volume":"250","author":"Ledneva","year":"2009","journal-title":"Radiology"},{"key":"10.1016\/j.diii.2021.01.007_bib0925","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.diii.2019.12.008","article-title":"Quantification of right ventricular extracellular volume in pulmonary hypertension using cardiac magnetic resonance imaging","volume":"101","author":"Habert","year":"2020","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.diii.2021.01.007_bib0930","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.diii.2020.05.010","article-title":"Association between background parenchymal enhancement and tumor response in patients with breast cancer receiving neoadjuvant chemotherapy","volume":"101","author":"Rella","year":"2020","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.diii.2021.01.007_bib0935","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.diii.2020.04.015","article-title":"Added value of MRI for the diagnosis of adnexal torsion in children and adolescents after inconclusive ultrasound examination","volume":"101","author":"Rougier","year":"2020","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.diii.2021.01.007_bib0940","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000149628","article-title":"Nephrogenic systemic fibrosis","volume":"29","author":"Nainani","year":"2009","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.diii.2021.01.007_bib0945","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1148\/radiol.2431062144","article-title":"Nephrogenic systemic fibrosis: risk factors and incidence estimation","volume":"243","author":"Sadowski","year":"2007","journal-title":"Radiology"},{"key":"10.1016\/j.diii.2021.01.007_bib0950","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/RLI.0000000000000000","article-title":"Incidence of nephrogenic systemic fibrosis in patients undergoing dialysis after contrast-enhanced magnetic resonance imaging with gadolinium-based contrast agents: the Prospective Fibrose Nephrog\u00e9nique Syst\u00e9mique study","volume":"49","author":"Amet","year":"2014","journal-title":"Invest Radiol"},{"key":"10.1016\/j.diii.2021.01.007_bib0955","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/jmri.25486","article-title":"Observational study on the safety profile of gadoterate meglumine in 35,499 patients: the SECURE study","volume":"45","author":"Soyer","year":"2017","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.diii.2021.01.007_bib0960","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/jamainternmed.2019.5284","article-title":"Risk of nephrogenic systemic fibrosis in patients with stage 4 or 5 chronic kidney disease receiving a group II gadolinium-based contrast agent: a systematic review and meta-analysis","volume":"180","author":"Woolen","year":"2020","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.diii.2021.01.007_bib0965","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/jmri.21981","article-title":"Removal of gadolinium by dialysis: review of different strategies and techniques","volume":"30","author":"Silberzweig","year":"2009","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.diii.2021.01.007_bib0970","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.carj.2019.04.001","article-title":"Updated clinical practice guideline on use of gadolinium-based contrast agents in kidney disease issued by the Canadian association of radiologists","volume":"70","author":"Schieda","year":"2019","journal-title":"Can Assoc Radiol J"}],"container-title":["Diagnostic and Interventional Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211568421000280?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211568421000280?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T17:36:24Z","timestamp":1761932184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211568421000280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":97,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S2211568421000280"],"URL":"https:\/\/doi.org\/10.1016\/j.diii.2021.01.007","relation":{},"ISSN":["2211-5684"],"issn-type":[{"value":"2211-5684","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kidney and contrast media: Common viewpoint of the French Nephrology societies (SFNDT, FIRN, CJN) and the French Radiological Society (SFR) following ESUR guidelines","name":"articletitle","label":"Article Title"},{"value":"Diagnostic and Interventional Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diii.2021.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Soci\u00e9t\u00e9 fran\u00e7aise de radiologie. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}